ONE-YEAR OBSERVATION OF TOPIRAMATE IN ADD-ON THERAPY IN PATIENTS WITH DRUG RESISTANT EPILEPSY
Journal Title: Acta Neuropsychologica - Year 2007, Vol 5, Issue 3
Abstract
[b]Introduction.[/b] Topiramate (Topamax, TPM) is an effective AED, used to treat simple partial, complex partial and secondary generalised to tonic seizures. The drug's pharmakokinetic profile and the outcomes of clinical trials suggest that TPM may be used in both polytherapy and monotherapy.[b]Objective.[/b] The aim of the study was to conduct a one-year observation of the effectiveness and safety of topiramate in patients with drug resistant epilepsy in the form of partial seizures with or without secondary generalisation.[b]Material and methods.[/b] 86 patients (36 F, 50 M) were studied. The mean age of the patients was 30 years (13-61) and the mean duration of epilepsy was 19 years (2-55). Thirty-seven (41.2%) of the 86 patients with partial seizures had secondary generalised seizures, 8 (8.9%) had secondary generalized to tonic-clonic seizures, and 41 (45.5%) had both types. The drug was administered twice daily for a mean daily dose of 5.2 mg/kg (0.8 - 11.7). The patients were observed for 12 months.[b]Results.[/b] Reduction of seizures by at least 50% was observed in 47 patients (54.7%), of whom 14 patients (16.3%) attained 100% relief of seizures, while seizure reduction exceeding 50% was observed in 33 patients (38.4%). Reduction of seizures by less than 50% was observed in 39 patients (45.3%). These figures were stable throughout the entire follow-up period. Side effects were registered and treatment was discontinued in 20% of the patients. Our clinical experience to date suggests that tolerance to TPM does not develop despite prolonged treatment with the drug. Only a small percentage of patients had to discontinue treatment due to clinical deterioration in the form of increased frequency of seizures.
Authors and Affiliations
Joanna Jędrzejczak, Krzysztof Owczarek
CHILDHOOD-ONSET ANOREXIA NERVOSA AND OBSESSIVE-COMPULSIVE DISORDER IN A MALE ADOLESCENT PATIENT: PROFILE OF NEUROCOGNITIVE FUNCTIONING
Background. Impairments of neurocognitive performance in female patientswith anorexia nervosa have been reported in many studies. To our knowledgeneuropsychological studies of male eating disorder patients remainrare. Th...
A MICROGENETIC APPROACH TO CREATMTY AND MYSTICISM
Creative insight and mystical union differ as to depth of with-drawal, which is a way of saying how closely they are bound to the phenomenal world. The difference between the creative and the mystical reflects disparitie...
COMPARISON OF COGNITIVE PROFILES IN CEREBRO-VASCULAR ACCIDENT AND TRAUMATIC BRAIN INJURY PATIENTS INTERNED AT IGNACE DEEN UNIVERSITY HOSPITAL OF GUINEA-CONAKRY
Cognitive and behavioral symptoms can be sequelae of both cerebro-vascular accident (CVA) and traumatic brain injury (TBI). In sub-Saharan African countries, including Guinea, there have been few studies focused on brain...
DEVELOPMENT OF AN ASSESSMENT BATTERY FOR READING AND WRITING DIFFICULTIES IN THE SECOND GRADE: SHOULD MEASURES OF HANDEDNESS BE INCLUDED?
[b]Background:[/b] This study investigated whether tasks assessing hand preference should be included in an assessment battery for reading and writing difficulties in the second grade. Central to the investigation was th...
Where is the spirit of the “vegetable”? (Minimally? Conscious?? State!)
Is “loss of consciousness” an appropriate term for a medical diagnosis? Does this terminology serve for decision making about treatment (initiation or termination)? Does unconsciousness mean no awareness of anything bey...